Weight loss injectables like Ozempic have gained popularity in Bengaluru, with patients sourcing them from abroad. The ...
Tirzepatide and Semaglutide Improve Weight Loss, Cardiovascular Conditions, but Deemed Too Expensive
Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...
Tirzepatide and semaglutide were associated with larger QALY gains (incremental gains of 0.35 and 0.25 over lifestyle ...
Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...
A real-world study of over 4,000 US patients without type 2 diabetes found that those who persisted with Tirzepatide for at ...
Viking Therapeutics has inked a $150m multi-year manufacturing deal with CordenPharma to secure the future supply of its ...
Empagliflozin is a SGLT-2 inhibitor and it has shown to significantly reduce the progression of kidney disease and heart failure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results